In today's market, several companies made headlines with significant financial results and strategic developments. Here are the key highlights:
- Wix reported robust Q2 2024 results, with total bookings up 15% year-over-year to $458.4 million. The company raised its full-year free cash flow outlook to $460 - $470 million. Read More
- ACM Research posted record revenue of $202.5 million, up 40% year-over-year, and raised its 2024 revenue outlook to $695-$735 million. Read More
- Oscar Health reported a 46% year-over-year revenue increase to $2.2 billion and raised its full-year revenue outlook to $9.0-$9.1 billion. Read More
- The GEO Group reported Q2 revenue of $607.2 million and a net loss of $0.25 per diluted share, following a comprehensive debt refinancing. Read More
- CVS Health reported a 2.6% increase in total revenues to $91.2 billion but decreased its full-year guidance due to underperformance in its Health Care Benefits segment. Read More
- PetIQ announced a definitive agreement to be acquired for $31 per share, representing a 41% premium. The company reported record Q2 revenue of $328.9 million, up 4.6% year-over-year. Read More
- Target Hospitality reported impressive Q2 results with revenue of $100.7 million and net income of $18.4 million, while projecting strong 2024 outcomes. Read More
- Novartis received FDA accelerated approval for Fabhalta® for IgA nephropathy, marking a significant advancement in treatment options. Read More
- Emerson reported a strong Q3 with net sales up 11% to $4.38 billion and updated its 2024 outlook, projecting net sales growth of approximately 15%. Read More
These notable developments reflect a dynamic market environment, showcasing both challenges and opportunities for growth across various sectors. Investors should stay informed as these companies navigate their respective landscapes.
